Latest filing published 11 Mar 2020 for Foamix Pharmaceuticals Ltd..
This profile gathers the share dealings of Anna Kazanchyan in Foamix Pharmaceuticals Ltd. In total, 8 filings cover trades dated from 8 May 2018 to 9 March 2020.
Sales make up the whole of the open-market record (3 sales, €47k). The rest of the record consists of 3 share grants.
On 11 March 2020 came the latest disclosure, a transaction in Foamix Pharmaceuticals Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations